brimonidine tartrate has been researched along with Anterior Optic Neuritis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azuchi, Y; Guo, X; Harada, C; Harada, T; Kimura, A; Mitamura, Y; Namekata, K; Noro, T; Semba, K; Yoshida, H | 1 |
Lagrèze, WA | 1 |
2 other study(ies) available for brimonidine tartrate and Anterior Optic Neuritis
Article | Year |
---|---|
Brimonidine suppresses loss of retinal neurons and visual function in a murine model of optic neuritis.
Topics: Administration, Ophthalmic; Adrenergic alpha-2 Receptor Agonists; Animals; Brimonidine Tartrate; Female; Mice, Inbred C57BL; Nerve Growth Factors; Neuroprotective Agents; Ophthalmic Solutions; Optic Neuritis; Quinoxalines; Retinal Neurons; Up-Regulation | 2015 |
[Neuroprotection. Bases and possibilities of a future clinical use].
Topics: Adrenergic alpha-Agonists; Animals; Apoptosis; Brimonidine Tartrate; Clinical Trials as Topic; Disease Models, Animal; Dopamine Agents; Eye Diseases; Forecasting; Glaucoma; Humans; Memantine; Neuroprotective Agents; Optic Neuritis; Quinoxalines; Retinal Diseases; Visual Fields | 2001 |